Effect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein

被引:139
作者
Wakasugi, H
Yano, I
Ito, T
Hashida, T
Futami, T
Nohara, R
Sasayama, S
Inui, K [1 ]
机构
[1] Kyoto Univ Hosp, Dept Pharm, Fac Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 606, Japan
关键词
D O I
10.1016/S0009-9236(98)90030-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We present a digoxin-clarithromycin interaction in two patients in whom digoxin concentrations were unexpectedly increased. The ratio of renal digoxin clearance to creatinine clearance in one patient was lower during the concomitant administration of clarithromycin (0.64 and 0.73) than that after cessation of clarithromycin administration (1.30 +/- 0.20; mean +/- SD), Because P-glycoprotein could play an important role in the renal secretion of digoxin, we hypothesized that clarithromycin decreases renal digoxin excretion by inhibiting P-glycoprotein-mediated transport. Digoxin transport was evaluated with use of a kidney epithelial cell line, which expresses the human P-glycoprotein on the apical membrane by transfection with MDR1 complementary deoxyribonucleic acid, Clarithromycin inhibited the transcellular transport of digoxin from the basolateral to the apical side in a concentration-dependent manner and concomitantly increased the cellular accumulation of digoxin, These results suggest that clarithromycin may inhibit the P-glycoprotein-mediated tubular secretion of digoxin, and this interaction mechanism may contribute to an increase in the serum digoxin concentration.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 24 条
[1]   Digoxin-itraconazole interaction: Possible mechanisms [J].
Alderman, CP ;
Allcroft, PD .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (04) :438-440
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Clarithromycin-associated digoxin toxicity in the elderly [J].
Brown, BA ;
Wallace, RJ ;
Griffith, DE ;
Warden, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :92-93
[4]   MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
CASALS, D ;
RITTMANGRAUER, L ;
BIEDLER, JL ;
MELAMED, MR ;
BERTINO, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) :695-698
[5]   CLARITHROMYCIN-INDUCED DIGOXIN TOXICITY IN A PATIENT WITH AIDS [J].
FORD, A ;
SMITH, LC ;
BALTCH, AL ;
SMITH, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) :1051-1052
[6]   ERYTHROMYCIN-INDUCED DIGOXIN TOXICITY [J].
FRIEDMAN, HS ;
BONVENTRE, MV .
CHEST, 1982, 82 (02) :202-202
[7]   REVERSAL OF DAUNORUBICIN RESISTANCE IN P388/ADR CELLS BY ITRACONAZOLE [J].
GUPTA, S ;
KIM, JM ;
GOLLAPUDI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1467-1469
[8]   REVERSAL OF DRUG-RESISTANCE BY ERYTHROMYCIN - ERYTHROMYCIN INCREASES THE ACCUMULATION OF ACTINOMYCIN-D AND DOXORUBICIN IN MULTIDRUG-RESISTANT CELLS [J].
HOFSLI, E ;
NISSENMEYER, J .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) :149-154
[9]  
Hori R, 1994, JPN J THER DRUG MONI, V11, P7
[10]  
Ito T, 1997, J PHARMACOL EXP THER, V282, P955